Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
GfV 2024
Programm
Poster
Personen
Suche
DE
Alle Personen
Dr. Alexandra Herrmann
Gräfelfing / DE
Immunic AG
Sortiert nach Typ
Datum
Vortrag
25.03.2024
Poster
P 078
Preclinical development of host-directed dual-target small molecule inhibitors as broad-spectrum antivirals
Antiviral therapy and resistance
Weitere Beteiligungen
25.03.2024
Poster
P 078
Preclinical development of host-directed dual-target small molecule inhibitors as broad-spectrum antivirals
Antiviral therapy and resistance
25.03.2024
Poster
P 315
Sensing of viral RNA lacking 2'-O-methylation induces a MDA5 dependent IFN response
Innate immunity
25.03.2024
16:15
–
16:30
12 Min.
3 Min.
Abstract talk
O 003
ORF3c is expressed in SARS-CoV-2-infected cells and suppresses IFN-β production by targeting MAVS
Emerging viruses
28.03.2024
11:00
–
11:15
12 Min.
3 Min.
Abstract talk
O 106
Characterization of Mpox virus genomes and patient isolates from Franconia (Bavaria, Germany) and antiviral testing of patient isolates
Antiviral therapy and resistance
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz